Skip to main content

Table 1 All ARVD/C, ARVD/C with (+ECG) and without (−ECG) 2010 ECG taskforce criteria

From: Right precordial-directed electrocardiographical markers identify arrhythmogenic right ventricular cardiomyopathy in the absence of conventional depolarization or repolarization abnormalities

  ARVC Total (N = 155) ECG-positive ARVC (N = 89) ECG-negative ARVC (N = 66) p-value
ECG-positive vs ECG-negative
Age 42.1 ± 17.3 42.0 ± 17.4 41.7 ± 17.6 0.861
Sex (% male) 106 (68.4%) 63 (70.8%) 43 (65.2%) 0.488
Proband (%) 111 (71.6%) 71 (79.8%) 30 (45.5%) 0.012
I. Imaging 155 (100%) 89 (100%) 66 (100%) 1.000
 major, % 111 (71.6%) 68 (76.4%) 43 (65.2%) 0.082
 minor, % 89 (57.4%) 60 (67.4%) 29 (43.9%) 0.005
II. Tissue characterization of the wall, biopsies performed (% of patients) 70 (45.2%) 39 (43.8%) 31 (47.0%) 0.745
 major, % 53 (75.7%) 31 (79.1%) 22 (71.0%) 0.576
 minor, % 63 (90.0%) 36 (92.3%) 27 (87.1%) 0.454
III. Repolarization abnormality     
 major, % 54 (34.8%) 54 (60.7%) 0 (0.0%) <0.001
 minor, % 20 (12.9%) 20 (22.5%) 0 (0.0%) <0.001
IV. Depolarization abnormality     
 major, % 13 (8.4%) 13 (14.6%) 0 (0.0%) <0.001
 minor, % 17 (11.0%) 17 (19.1%) 0 (0.0%) <0.001
V. Arrhythmia     
 major, % 44 (28.4%) 26 (29.2%) 18 (27.3%) 0.858
 minor, % 64 (41.3%) 42 (47.2%) 22 (33.3%) 0.1000
VI. Family history     
 major, % 84 (54.2%) 48 (53.9%) 35 (53.0%) 1.000
VII. Genotype positive 48 (31.0%) 29 (32.6%) 19 (28.8%) 0.726
 PLN (% genotype positive) 1 (2.1%) 0 (0.0%) 1 (5.3%) 0.396
 TTN (% genotype positive) 11 (22.9%) 8 (27.6%) 3 (15.8%) 0.488
 PKP2 (% genotype positive) 23 (47.9%) 17 (58.6%) 6 (31.2%) 0.083
 DSC2 (% genotype positive) 2 (4.2%) 1 (3.5%) 1 (5.3%) 1.000
 DSG2 (% genotype positive) 12 (25.0%) 6 (20.7%) 6 (31.5%) 0.501
 DSG3 (% genotype positive) 2 (4.2%) 1 (3.5%) 1 (5.30%) 1.000
 DSP (% genotype positive) 8 (16.7%) 6 (20.7%) 2 (10.56%) 0.4510